Acadia Pharmaceuticals | Crediti Commerciali



Trade Debtors Cambiamento Data
Acadia Pharmaceuticals USD 104.7M 5.67M 2024-12
ALKERMES USD 394.72M 24.54M 2024-12
Alnylam Pharmaceuticals USD 405.31M 51.46M 2024-12
Biogen USD 1.87B 119.3M 2024-12
BioMarin Pharmaceutical USD 660.54M 117.01M 2024-12
Bristol-Myers Squibb USD 14.42B 471M 2024-12
Corcept Therapeutics USD 53.98M 5.74M 2024-12
Cytokinetics USD 16.65M 16.41M 2024-12
Eisai JPY 235.64B 40.42B 2024-12
Eli Lilly USD 13.28B 1.22B 2024-12
Incyte USD 853.15M 94.7M 2024-12
Intra Cellular Therapies USD 166.5M 20.89M 2024-12
J&J USD 14.84B 1.33B 2024-12
Moderna USD 592M 1.24B 2024-12
Neurocrine Biosciences USD 479.1M 2M 2024-12
Pfizer USD 14.78B 2.92B 2024-12
Prothena USD 0 0 2024-12
PTC Therapeutics USD 158.55M 41.42M 2024-12
Sarepta Therapeutics USD 649.73M 133.74M 2024-12
Ultragenyx Pharmaceutical USD 123.6M 28.5M 2024-12
Vertex Pharmaceuticals USD 1.61B 141.2M 2024-12



Acadia Pharmaceuticals Crediti Commerciali - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.